Trial Details

TERMINATED
Basic Information
Clinical ID c4028
Identifier NCT01162889
Trial Title Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy People
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Healthy
Interventions DRUG: Placebo SC Injection|DRUG: ATR-107 (PF-05230900) SC Injection|DRUG: ATR-107 (PF-05230900) SC Injection|DRUG: ATR-107 (PF-05230900) SC Injection|DRUG: ATR-107 (PF-05230900) SC Injection|DRUG: ATR-107 (PF-05230900) SC Injection|DRUG: ATR-107 (PF-05230900) IV Infusion|DRUG: ATR-107 (PF-05230900) IV Infusion|DRUG: ATR-107 (PF-05230900) IV Infusion|DRUG: Placebo IV Infusion|DRUG: ATR-107 (PF-05230900) IV Infusion
Participant Information
Sponsor Pfizer
City New Haven
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2010-06
Primary Completion Date 2012-01
Completion Date 2012-01